2026 COA Annual Meeting Day 2: How Multidisciplinary Teams Form a Comprehensive Approach

How Multidisciplinary Teams Form a Comprehensive Approach to Digitally-derived Endpoints Moderator: Cheryl D. Coon, PhD – Vice President, Clinical Outcome Assessment Program, Critical Path Institute Presenters: Tom Willgoss, PhD – Immunology Lead, Roch Products, Ltd Marie McCarthy – Digital Endpoint Lead Director, Novartis Panelists: Andrew Potter, PhD – Associate Director, Biostatistics, BMS Abigail Newell, PhD – Senior Director, Research, Cancer Support Community Liam Kaufman, MS – Executive VP, Partnerships and Strategic Projects, Cambridge Cognition This session will explore how collaboration across disciplines can strengthen the development and implementation of digitally-derived endpoints in clinical research. Through examples and discussion, the session will: Share success stories where a multidisciplinary team provided the insight needed for a promising digitally-derived endpoint strategy Share strategies for engaging with necessary experts for a comprehensive approach to digitally-derived endpoints SUBSCRIBE to C-Path's YouTube Channel Now ►►    / criticalpathinstitute   FOLLOW C-Path: ►LinkedIn:   / c-path   ►Facebook:   / cpathinstitute   ►Twitter: https://twitter.com/CPathInstitute?re About Critical Path Institute C-Path is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org. #CPath #drugdiscovery #researchgrants #globalhealth #drugdevelopment #datasharing #researchfunding #raredisease #academicresearch #regulatoryscience #globalhealth #consortia #collaboration